Your Good Partner in Biology Research

  1. 首页
  2. 试剂盒
  3. 酶联免疫试剂盒
  4. Human Properdin(CFP) ELISA kit

Human Properdin(CFP) ELISA kit

  • 中文名称：
    人备解素(CFP)酶联免疫试剂盒
  • 货号：
    CSB-EL005291HU
  • 规格：
    96T/48T
  • 价格：
    ￥3600/￥2500
  • 其他：

产品详情

  • 产品描述：

    This Human CFP ELISA Kit was designed for the quantitative measurement of Human CFP protein in serum, plasma, cell culture supernates, tissue homogenates. It is a Sandwich ELISA kit, its detection range is 12.5 ng/mL-800 ng/mL and the sensitivity is 3.12 ng/mL.

  • 别名：
    BFD ELISA Kit; CFP ELISA Kit; Complement factor P ELISA Kit; Complement factor properdin ELISA Kit; Factor P ELISA Kit; PFC ELISA Kit; PFD ELISA Kit; PROP_HUMAN ELISA Kit; Properdin ELISA Kit; Properdin P factor complement ELISA Kit
  • 缩写：
    CFP
  • Uniprot No.：
  • 种属：
    Homo sapiens (Human)
  • 样本类型：
    serum, plasma, cell culture supernates, tissue homogenates
  • 检测范围：
    12.5 ng/mL-800 ng/mL
  • 灵敏度：
    3.12 ng/mL
  • 反应时间：
    1-5h
  • 样本体积：
    50-100ul
  • 检测波长：
    450 nm
  • 研究领域：
    Immunology
  • 测定原理：
    quantitative
  • 测定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 线性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of human CFP in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    SampleSerum(n=4)
    1:100Average %95
    Range %90-100
    1:200Average %106
    Range %101-110
    1:400Average %98
    Range %92-103
    1:800Average %90
    Range %85-97
  • 回收率：
    The recovery of human CFP spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 8480-90
    EDTA plasma (n=4)9389-98
  • 标准曲线：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/ml OD1OD2AverageCorrected
    8002.378 2.224 2.301 2.200
    4001.754 1.852 1.803 1.702
    2001.088 1.124 1.106 1.005
    1000.687 0.642 0.665 0.564
    500.364 0.383 0.374 0.273
    250.245 0.233 0.239 0.138
    12.50.171 0.162 0.167 0.066
    00.098 0.104 0.101
  • 数据处理：
  • 货期：
    3-5 working days

产品评价

靶点详情

  • 功能：
    A positive regulator of the alternate pathway (AP) of complement. It binds to and stabilizes the C3- and C5-convertase enzyme complexes. Inhibits CFI-CFH mediated degradation of Complement C3 beta chain (C3b).
  • 基因功能参考文献：
    1. In conclusion, we challenge the view of properdin as a pattern recognition molecule by providing evidence that it binds to different exogenous and endogenous molecular patterns in only a C3-dependent manner. PMID: 28069958
    2. data indicate that properdin enhances platelet/granulocyte aggregates (PGAs) formation via increased production of C5a, and that inhibition of properdin function has therapeutic potential to limit thromboinflammation in diseases characterized by increased PGA formation PMID: 27183616
    3. this study shows that RNA interference of properdin in dendritic cells decreased alloantigen-specific T-cell proliferation PMID: 28105653
    4. studies demonstrate an essential role of properdin oligomerization in vivo while our monomers enable detailed structural insight paving the way for novel modulators of complement. PMID: 28264884
    5. P serum level expression could be a reliable clinical biomarker to identify patients with underlying surface alternative pathway C5 convertase dysregulation. PMID: 26660535
    6. can directly interact with neutrophil myeloperoxidase resulting in activation of alternative pathway of complement PMID: 24355864
    7. In the pathogenesis of renal tubular damage, P can directly bind to PTECs and may accelerate AP activation by surpassing fH regulation PMID: 24885016
    8. Our data show that physiological forms of human properdin bind directly to human platelets after activation by strong agonists in the absence of C3 PMID: 23677468
    9. Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate. PMID: 22815489
    10. Properdin released from human polymorphonuclear cells does not bind to zymosan or E. coli, but when incubated in properdin-depleted serum this form of properdin binds efficiently to both substrates in a strictly complement C3-dependent manner. PMID: 22851705
    11. Properdin and SC5b-9 may be novel biomarkers for future risk of type 2 diabetes in this high-risk population and warrant further investigation. PMID: 22338105
    12. Immune human serum that contained bactericidal Abs directed against the 2C7 lipooligosaccharide epitope required functional properdin to kill C4BP-binding strains, but not C4BP-nonbinding strains. PMID: 22368277
    13. report a large Finnish family with a novel mutation in the properdin gene. The mutation is located in exon 9 and changes guanine to adenine at nucleotide 1164 (c.1164G>A) that causes tryptophan to change to a premature stop codon (W388X). PMID: 22229731
    14. tubular HS as a novel docking platform for alternative pathway activation via properdin, which might play a role in proteinuric renal damage. PMID: 21135110
    15. levels of properdin are not associated with childhood wheezing and atopy PMID: 20337960
    16. Human properdin can selectively recognize surfaces and enhance or promote alternative pathway of complement activation. PMID: 20382442
    17. The conventional mechanism of properdin function is to bind to and stabilize alternative pathway C3 convertases on the surface of Neisseria meningitidis and N. gonorrhoeae. PMID: 20530262
    18. Properdin presence is associated with increased SC5b-9 excretion and worse renal function. PMID: 19934084
    19. CFP does not seem to confer any risk for age-related macular degeneration. PMID: 20122735
    20. A splice site mutation in exon 10 (c.1487-2A>G) was found in the properdin gene and co segregated with biochemically measured properdin deficiency. PMID: 16337490
    21. study reports properdin binds predominantly to late apoptotic & necrotic cells but not to early apoptotic cells; binding occurs independently of C3b PMID: 18490764
    22. The human complement protein properdin binds to early apoptotic T cells and initiates complement activation, leading to C3b opsonization and ingestion by phagocytic cells. PMID: 18579773
    23. The contribution of properdin is pivotal in proteinuria-induced tubular complement activation and subsequent damage. Interference with properdin binding to tubular cells may provide an option for the treatment of proteinuric renal disease. PMID: 18753294
    24. Properdin induces the formation of platelet-leukocyte aggregates via leukocyte activation, linking the complement system & platelet-leukocyte aggregates with potential significance in atherosclerotic vascular disease. PMID: 18791942
    25. Significantly more transcripts encoding alternative pathway components factor B, C3 and properdin, and C3a receptor and C5a receptor were detected in grade 3 versus grade 0 or 1 biopsies of human cardiac allografts. PMID: 19005416
    26. Factor P was expressed in 50% of choroidal neovascular membranes of patients with age-related macular degeneration(AMD). Additional studies need to investigate role of Factor P in development of AMD for potential therapeutic intervention. PMID: 19584655

    显示更多

    收起更多

  • 相关疾病：
    Properdin deficiency (PFD)
  • 亚细胞定位：
    Secreted.
  • 数据库链接：

    HGNC: 8864

    OMIM: 300383

    KEGG: hsa:5199

    STRING: 9606.ENSP00000247153

    UniGene: Hs.53155